Alkylating Agent-Related Acute Myeloid Leukemia: Clinical Trials

2 trials for Alkylating Agent-Related Acute Myeloid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Alkylating Agent-Related Acute Myeloid Leukemia: new trials by email Literature Review of Alkylating Agent-Related Acute Myeloid Leukemia trials Research Report on Alkylating Agent-Related Acute Myeloid Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis - Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia
Phase 3CompletedChildren's Oncology Group5172011-04-042021-03-30
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Clinical Observation, Tipifarnib - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Phase 3CompletedNational Cancer Institute (NCI)1442004-08-182026-07-14

Narrower conditions

Leukemia, Monocytic, Acute (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myelomonocytic, Acute (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Invasive Fungal Infections (1)  ·  Leukemia (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Mycoses (1)  ·  Neutropenia (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia, Myeloid (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Agranulocytosis (1)  ·  Anemia (1)  ·  Anemia, Refractory (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bone Marrow Diseases (1)  ·  Cytopenia (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)

Interventions

Caspofungin (1)  ·  Fluconazole (1)  ·  Observation (1)  ·  Watchful Waiting (1)  ·  tipifarnib (1)

Sponsors

Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Canada (1)  ·  Israel (1)  ·  Peru (1)  ·  Puerto Rico (1)

Top investigators

Selina Luger (1)  ·  Theoklis E Zaoutis (1)

Results publications

PMID 31688884

NIH funding

U10CA021115 (1), U10CA095861 (1), U10CA180820 (1), UG1CA189955 (1)